S. A. Muslimov

S. A. Muslimov

Auto-generated profile, based on publicly available information

S. A. Muslimov

Federal State Budgetary Education Institution «Bashkir State Medical University

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2005 in Cell and Tissue Banking
Verified
Journal Article
Closed access
PDF file
EME.R. Muldashev
E.R. Muldashev
SMS.A. Muslimov
S.A. Muslimov
LML.A. Musina
L.A. Musina
RNR.T. Nigmatullin
R.T. Nigmatullin
ALA.I. Lebedeva
A.I. Lebedeva
RKR.A. Khasanov
R.A. Khasanov

1 January 1999 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
EME.R. Muldashev
E.R. Muldashev
SMS.A. Muslimov
S.A. Muslimov
RNR.T. Nigmatullin
R.T. Nigmatullin
YKY.I. Kiiko
Y.I. Kiiko
VGV.U. Galimova
V.U. Galimova
LML.A. Musina
L.A. Musina
Purpose: To reduce antigenicity of allografts and stimulate their replacement by natural recipient tissues. Methods: Experimental allotransplantation of different tissues (fascias, tendons, derma, fat, etc.) with histological, histochemical, electron microscopical, electron histochemical examination 3, 5, 7, 14, 21, 30, 60, 120, 180 and 360 days postoperatively. Results: Allografts of different tissues with glucosaminoglycans extracted from collagen fibers have low antigenicity and can be replaced by natural tissues. Allografts with these properties were named ‘Alloplant’. Conclusions: Alloplant biomaterials can selectively stimulate natural tissue regeneration. Hence, Alloplant biomaterilas can be utilized in surgery for the restoration of different tissues.

6 December 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ALAnna Lebedeva
Anna Lebedeva
SMS. A. Muslimov
S. A. Muslimov
EGE. M. Gareev
E. M. Gareev
SPSergey Popov
Sergey Popov
SAS. A. Afanasiev
S. A. Afanasiev
Summary. Local progenitor cells are present in all tissues, including the myocardium. Stimulation of these cells can significantly improve the efficiency of the regeneration process. Biodegradation products of Alloplant biomaterials (ABM) are an inhibitor of fibrosis and serve as an inducer of stem cells in various body tissues including smooth and skeletal muscles, as well as connective tissue.Aim. To determine the cell regenerative potential of progenitorial c-kit and committed GATA-4 cells in ischemic myocardium on the background of ABM application in chronic experiment.Materials and methods. 100 Wistar rats weighing 180-200g were used, that underwent ligation of coronary artery. In the experimental group (n = 50), 600 μl of a physiological solution containing 12 mg of ABM was administered simultaneously with coronary occlusion. General histological studies (hematoxylin and eosin staining, and staining as per Mallory), immunohistochemical (c-kit, GATA-4) and morphometric studies (determination of the index of the scar's area, counting of stained cells) were carried out. The statistical processing of the results was carried out using the rank methods - single factor dispersion analysis as per Kruskalou-Wallace and the comparison of uncorrelated data by the Mann-Whitney method.Results. When using ABM during coronary occlusion, myocardium was characterized by a statistically significant (p <0.0001) prevalence of c-kit+ / GATA-4+ cells numbers throughout the follow-up period (3-45 days). These cells were localized mainly in the granulation tissue of the peri-cicatricial area, bordering on the preserved cardiac muscle tissue. In the peri-cicatricial area, cardiac cells had a different degree of maturity - from poorly differentiated forms (without clear ultrastructural signs of cardiomyogenic orientation) to young cardiomyocytes. In the presence of ABM, coronary occlusion was characterized by statistically significantly smaller values of the index of the scar's area (p <0,05 ÷ <0,0001).Conclusion. ABM degradation products are chemoattractants for c-kit cells and promote their differentiation into cardiomyogenic GATA-4 cells, which contributes to more successful myocardium repair.

14 August 2018 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
ALAnna Lebedeva
Anna Lebedeva
SMS. A. Muslimov
S. A. Muslimov
EGE. M. Gareev
E. M. Gareev
SPSergey Popov
Sergey Popov
SAS. A. Afanasyev
S. A. Afanasyev
DКD. S. Кondratyeva
D. S. Кondratyeva
Aim. To assess the expression of ММР-9 and TIMP-2 after intramyocardial injection of the allogenic biomaterial (AB) into ischemized myocardium in rodents.Material and methods.One hundred Wistar rodents were used, who underwent ligation of coronary artery. The experiment group (n=50), together with coronary occlusion, received the suspension of AB 12 mg. General histology was applied: hematoxyline and eosine, by Mallori; immune histochemistry (ММP-9, TIMP-2, CD68); morphometry: index of the scar area (ISA), amount of ММP-9, TIMP-2, CD68-positive cells.Results.It was shown that in the experimental group, after implantation of AB there were lesser than in controls values of ISA (2,74 times, p<0,05 . <0,0001), numbers of MMP9+ cells (p<0,001) and macrophages CD68+ (p<0,05), as the manifestation of proteolysis and area of lesion. On the contrary, amount of Timp-2+ cells in the experimental group was higher than in the control (p<0,0004).Conclusion.Resorption of allogenic material (Alloplant) products does influence the balance of metalloproteinases and their inhibitors in the myocardium after ischemic lesion. This effect might influence the processes of myocardial remodelling and scar formation.

16 April 2020 in Bulletin of Siberian Medicine
Verified
Journal Article
Open access
PDF file
ALAnna Lebedeva
Anna Lebedeva
SMS. A. Muslimov
S. A. Muslimov
EGE. M. Gareev
E. M. Gareev
SAS. A. Afanasiev
S. A. Afanasiev
DCD. S. Condratyeva
D. S. Condratyeva
SPSergey Popov
Sergey Popov
Макрофаги как регуляторы гомеостаза миокарда после его ишемического повреждения в условиях применения аллогенного биоматериала

5 April 2023 in Medical Immunology (Russia)
Verified
Journal Article
Open access
PDF file
ALAnna Lebedeva
Anna Lebedeva
EGE. M. Gareev
E. M. Gareev
SAS. A. Afanasiev
S. A. Afanasiev
DKD. S. Kondratieva
D. S. Kondratieva
SMS. A. Muslimov
S. A. Muslimov
SPSergey Popov
Sergey Popov
Injectable allogeneic decellularized biomaterials are being developed both as scaffolds for delivery of cellular products and as independent pharmacological agents that affect the cascade of tissue reactions during the period of post-ischemic myocardial remodeling. Biomaterial degradation products can affect cellular processes and modulate cytokine effects, thus determining the healing strategy of damaged tissue. In this work, the influence of biomaterial on the expression of key fibrogenic factors by the cells of tissue bed was demonstrated, and the degree of damage to the myocardium during its ischemic damage was experimentally determined. The aim of our study was to determine the area of myocardial scar degeneration and detection of key fibrogenic factors (bFGF-1, TGFb1, MMP-9), as well as TIMP-2 (MMP-9 antagonist) at the acute and subacute stages of myocardial infarction after implantation of allogeneic powder-like biomaterial in an experimental model.In the course of experiments, the left ventricular coronary artery was ligated in male Wistar rats (experimental group). All animals were divided into 3 groups: experimental group I (n = 50), experimental group II (n = 50), and controls (n = 50). In experimental group I, the artery ligation was simultaneously accompanied by intramyocardial administration of powder-like biomaterial suspension (2 mg). In experimental group II, the allogeneic powder-like biomaterial was administered 5 days after coronary occlusion, and only physiological saline was administered in the control group. The animals were withdrawn from experiment on days +3, +7, +14, +30, and +45. Standard histological assessment (hematoxylin and eosin staining, according to Mallory) and immunohistochemical examination (MMP-9, TGFb1, bFGF-1, TIMP-2) were made, and statistical evaluation was performed. The cells with positive staining were counted, and the scar area index was calculated.We have found that administration of dispersed allogeneic biomaterial was followed by a five-fold decrease in the degree of scar degeneration in both experimental groups at the acute and subacute stages of ischemic myocardial damage as compared to the control group. A significantly decreased expression of fibrogenic factors (MMP-9, TGFb1, bFGF-1) by the local cells was found, along with increased activity of metalloproteinase inhibitor (TIMP-2) in connective tissue cells.Decellularized allogeneic powder-like biomaterial serves as a fibrosis inhibitor and promotes cardioprotection during myocardial remodeling at the initial stages after ischemic injury.